Angebote zu "Into" (8 Treffer)

Kategorien

Shops

Financing in life sciences biotech companies
27,90 CHF *
zzgl. 3,50 CHF Versand

Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, grade: 1,3, Pforzheim University, course: Corporate Finance, 25 entries in the bibliography, language: English, abstract: Biotechnology is a more and more important field of research in present. Publicly we are currently confronted with many questions about the rights and wrongs within this field of science, like how to handle the issue of gene manipulation or stem cell research. However, biotechnology is more than just an accumulation of ethical questions and science - it is a whole industry and as such interesting for investors. The scope of this paper is not dealing with the topics discussed in glossy magazines, but it addresses the issues of corporate finance in biotechnology. In order to get an overview of the industry from a finance point of view, the industry has to be portrayed. Hence, this is the topic of chapter two. From the point of the investors, and therefore of the capital markets, the understandability of the segment biotechnology, and thus the availability of crucial information has to be ensured. Consequently the transparency of the biotechnology segment and of the individual enterprises, respectively, are the topics of the third chapter. The implications of this chapter have a strong impact on the valuation of biotechnological companies and the sector as a whole - a subject dealt with in chapter number four. The fifth chapter is concerned with the core topic of this paper and identifies and analyses different sources of finance for biotechnology enterprises. Thereby it is taking the point of view of the biotechnology firms and the potential investors. The paper is showing important difficulties and advantages connected with the different approaches. Additionally the chapter also describes and evaluates the risks of different options of investors. The paper is concluded with a summary of the findings in chapter six showing that investing into biotechnology is worth thinking about for a responsible and sophisticated investor, although the segment is a difficult field incurring many risks, however opportunities for the 'big win', as well.

Anbieter: Orell Fuessli CH
Stand: 07.04.2020
Zum Angebot
Insights Into Lyme Disease Treatment: 13 Lyme-L...
63,90 CHF *
ggf. zzgl. Versand

PRAISE FROM OTHER LYME AUTHORS: 'A wealth of valuable information, and an excellent resource ... especially for patients looking for novel, non-toxic healing therapies to augment (or possibly replace) standard allopathic therapies ... this book should be in the library of all Lyme patients.' -KENNETH SINGLETON, M.D., M.P.H. Author of 'The Lyme Disease Solution' 'One of the most important books on Lyme disease treatment published in the past decade-an essential resource for both clinicians and those suffering from Lyme.' -STEPHEN HARROD BUHNER Author of 'Healing Lyme: Natural Healing and Prevention of Lyme Borreliosis And Its Coinfections' FROM THE PUBLISHER: If you traveled the country for appointments with thirteen Lyme-literate health care practitioners, you would discover many of the cutting-edge therapies used to combat chronic Lyme disease. You would also spend thousands of dollars on hotels, plane tickets, and medical appointment fees-not to mention the time that it would take to embark on such a journey. Even if you had the time and money to travel, would the physicians have enough time to answer all of your questions? Would you even know which questions to ask? In this long-awaited book, health care journalist Connie Strasheim has done all the work for you. She conducted intensive interviews with thirteen of the world's most competent Lyme disease healers, asking them thoughtful, important questions, and then spent months compiling their information into organized, user-friendly chapters that contain the core principles upon which they base their medical treatment of chronic Lyme disease. The specific practitioners interviewed represent a variety of medical disciplines, including allopathic, naturopathic, complementary, chiropractic, homeopathic, and energy medicine. Two European physicians were also interviewed. PHYSICIANS INTERVIEWED: * Steven J. Harris, M.D., Redwood City, CA * Steven Bock, M.D., Rhinebeck, NY * Susan Marra, M.S., N.D., Seattle, WA * Ginger Savely, DNP, San Francisco, CA * W. Lee Cowden, M.D., M.D. (H), Panama City, Panama * Ingo D. E. Woitzel, M.D., Pforzheim, Germany * Ronald Whitmont, M.D., Rhinebeck, NY * Deborah Metzger, Ph.D., M.D., Los Altos, CA * Peter J. Muran, M.D., M.B.A., San Luis Obispo, CA * Nicola McFadzean, N.D., San Diego, CA * Marlene Kunold, HCP, Hamburg, Germany * Elizabeth Hesse-Sheehan, DC, CCN, Kirkland, WA * Jeffrey Morrison, M.D., New York, NY All aspects of treatment are covered, from anti-microbial remedies and immune system support, to hormonal restoration, detoxification, dietary and lifestyle choices. Furthermore, the book ponders patient and practitioner challenges of treating chronic Lyme disease, and offers helpful insights to the friends and families of those coping with chronic illness. Patients can use this book to get new treatment ideas and to educate their local physicians. Practitioners can use it to learn about and stay current on the latest therapies. Lyme disease treatment is complex and controversial, and this book puts the treatment information you need in the palm of your hand.

Anbieter: Orell Fuessli CH
Stand: 07.04.2020
Zum Angebot
The Dell Company - A Strategic Analysis
14,90 CHF *
ggf. zzgl. Versand

Seminar paper from the year 2005 in the subject Business economics - Business Management, Corporate Governance, grade: 1,0, Pforzheim University, course: Management Seminar SS 2005, 20 entries in the bibliography, language: English, abstract: 'No other technology company listens to customers, collaborates with partners, adds its own significant layer of innovation and delivers relevant technology more efficiently and effectively than Dell.' These words from Michael Dell point out more than anything else how the Dell company managed to advance to the worldwide number one in the computer industry. From a little company founded by an undergraduate student at the University of Texas, Dell Inc., headquartered in Round Rock, Texas, has developed into a huge corporation with more than 55,200 employees today and an annual turnover of nearly $50 billion. This report aims to analyse how the Dell company performs in the competitive environment of the computer industry, which factors are essential for success and how Dell successfully takes advantage of its business structure. Furthermore, an internal analysis will be conducted and the resulting strengths and weaknesses will be presented. The future developments of the computer industry in general and of the Dell company in particular, will be examined at the end of this paper.

Anbieter: Orell Fuessli CH
Stand: 07.04.2020
Zum Angebot
Prägen, Stanzen, Guillochieren / Embossing, Pun...
28,80 € *
ggf. zzgl. Versand

Embossing, punching and guilloche engraving are techniques that have almost faded into oblivion. These trailblazing manufactory production methods were crucial to the rise of Pforzheim’s jewellery industry in the nineteenth century. Today they are experiencing a new lease of life in contemporary jewellery. The ‘Manufactory-Style Jewellery Design’ project fosters the passing down of experiential knowledge through the collaboration of artisans and designers from three generations. In 2005 the German Commission for UNESCO recorded the project in the German Register of ‘Best Safeguarding Practices for Intangible Cultural Heritage’. This book presents an excerpt of this success story by means of archive material and interviews with former masters, explains how the machines work, and illustrates many examples of how these traditional techniques can be put to use in contemporary art jewellery.

Anbieter: Thalia AT
Stand: 07.04.2020
Zum Angebot
Financing in life sciences biotech companies
16,50 € *
zzgl. 3,00 € Versand

Seminar paper from the year 2006 in the subject Business economics - Investment and Finance, grade: 1,3, Pforzheim University, course: Corporate Finance, 25 entries in the bibliography, language: English, abstract: Biotechnology is a more and more important field of research in present. Publicly we are currently confronted with many questions about the rights and wrongs within this field of science, like how to handle the issue of gene manipulation or stem cell research. However, biotechnology is more than just an accumulation of ethical questions and science - it is a whole industry and as such interesting for investors. The scope of this paper is not dealing with the topics discussed in glossy magazines, but it addresses the issues of corporate finance in biotechnology. In order to get an overview of the industry from a finance point of view, the industry has to be portrayed. Hence, this is the topic of chapter two. From the point of the investors, and therefore of the capital markets, the understandability of the segment biotechnology, and thus the availability of crucial information has to be ensured. Consequently the transparency of the biotechnology segment and of the individual enterprises, respectively, are the topics of the third chapter. The implications of this chapter have a strong impact on the valuation of biotechnological companies and the sector as a whole - a subject dealt with in chapter number four. The fifth chapter is concerned with the core topic of this paper and identifies and analyses different sources of finance for biotechnology enterprises. Thereby it is taking the point of view of the biotechnology firms and the potential investors. The paper is showing important difficulties and advantages connected with the different approaches. Additionally the chapter also describes and evaluates the risks of different options of investors. The paper is concluded with a summary of the findings in chapter six showing that investing into biotechnology is worth thinking about for a responsible and sophisticated investor, although the segment is a difficult field incurring many risks, however opportunities for the 'big win', as well.

Anbieter: Thalia AT
Stand: 07.04.2020
Zum Angebot
Insights Into Lyme Disease Treatment: 13 Lyme-L...
46,99 € *
ggf. zzgl. Versand

PRAISE FROM OTHER LYME AUTHORS: 'A wealth of valuable information, and an excellent resource ... especially for patients looking for novel, non-toxic healing therapies to augment (or possibly replace) standard allopathic therapies ... this book should be in the library of all Lyme patients.' -KENNETH SINGLETON, M.D., M.P.H. Author of 'The Lyme Disease Solution' 'One of the most important books on Lyme disease treatment published in the past decade-an essential resource for both clinicians and those suffering from Lyme.' -STEPHEN HARROD BUHNER Author of 'Healing Lyme: Natural Healing and Prevention of Lyme Borreliosis And Its Coinfections' FROM THE PUBLISHER: If you traveled the country for appointments with thirteen Lyme-literate health care practitioners, you would discover many of the cutting-edge therapies used to combat chronic Lyme disease. You would also spend thousands of dollars on hotels, plane tickets, and medical appointment fees-not to mention the time that it would take to embark on such a journey. Even if you had the time and money to travel, would the physicians have enough time to answer all of your questions? Would you even know which questions to ask? In this long-awaited book, health care journalist Connie Strasheim has done all the work for you. She conducted intensive interviews with thirteen of the world's most competent Lyme disease healers, asking them thoughtful, important questions, and then spent months compiling their information into organized, user-friendly chapters that contain the core principles upon which they base their medical treatment of chronic Lyme disease. The specific practitioners interviewed represent a variety of medical disciplines, including allopathic, naturopathic, complementary, chiropractic, homeopathic, and energy medicine. Two European physicians were also interviewed. PHYSICIANS INTERVIEWED: * Steven J. Harris, M.D., Redwood City, CA * Steven Bock, M.D., Rhinebeck, NY * Susan Marra, M.S., N.D., Seattle, WA * Ginger Savely, DNP, San Francisco, CA * W. Lee Cowden, M.D., M.D. (H), Panama City, Panama * Ingo D. E. Woitzel, M.D., Pforzheim, Germany * Ronald Whitmont, M.D., Rhinebeck, NY * Deborah Metzger, Ph.D., M.D., Los Altos, CA * Peter J. Muran, M.D., M.B.A., San Luis Obispo, CA * Nicola McFadzean, N.D., San Diego, CA * Marlene Kunold, HCP, Hamburg, Germany * Elizabeth Hesse-Sheehan, DC, CCN, Kirkland, WA * Jeffrey Morrison, M.D., New York, NY All aspects of treatment are covered, from anti-microbial remedies and immune system support, to hormonal restoration, detoxification, dietary and lifestyle choices. Furthermore, the book ponders patient and practitioner challenges of treating chronic Lyme disease, and offers helpful insights to the friends and families of those coping with chronic illness. Patients can use this book to get new treatment ideas and to educate their local physicians. Practitioners can use it to learn about and stay current on the latest therapies. Lyme disease treatment is complex and controversial, and this book puts the treatment information you need in the palm of your hand.

Anbieter: Thalia AT
Stand: 07.04.2020
Zum Angebot
The Dell Company - A Strategic Analysis
11,99 € *
ggf. zzgl. Versand

Seminar paper from the year 2005 in the subject Business economics - Business Management, Corporate Governance, grade: 1,0, Pforzheim University, course: Management Seminar SS 2005, 20 entries in the bibliography, language: English, abstract: 'No other technology company listens to customers, collaborates with partners, adds its own significant layer of innovation and delivers relevant technology more efficiently and effectively than Dell.' These words from Michael Dell point out more than anything else how the Dell company managed to advance to the worldwide number one in the computer industry. From a little company founded by an undergraduate student at the University of Texas, Dell Inc., headquartered in Round Rock, Texas, has developed into a huge corporation with more than 55,200 employees today and an annual turnover of nearly $50 billion. This report aims to analyse how the Dell company performs in the competitive environment of the computer industry, which factors are essential for success and how Dell successfully takes advantage of its business structure. Furthermore, an internal analysis will be conducted and the resulting strengths and weaknesses will be presented. The future developments of the computer industry in general and of the Dell company in particular, will be examined at the end of this paper.

Anbieter: Thalia AT
Stand: 07.04.2020
Zum Angebot